HOME › DRUGS › SILTUXIMAB
ACTIVE SUBSTANCE / INN

SILTUXIMAB

Brand name(s): Sylvant, SYLVANT
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
BLA125496
Giant Lymph Node Hyperplasia
ACTIVE SUBSTANCE
Siltuximab
REGULATORS
FDA · EMA
SPONSORS / MAH
RECORDATI RARE DISEASES, INC., Recordati Netherlands B.V.
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
SYLVANTBLA125496RECORDATI RARE DISEASES, INC.Prescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
SylvantRecordati Netherlands B.V.Authorised22/05/2014Giant Lymph Node Hyperplasia

FULL INTELLIGENCE ON SILTUXIMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →